首頁 > 市場調查報告書 > 製藥

全球皮膚過敏治療市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

市場調查報告書

商品編碼

1409000

全球皮膚過敏治療市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Skin Allergy Therapeutics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年01月01日 | 出版商:

Value Market Research | 英文 173 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計到 2030 年，全球皮膚過敏治療市場的需求將從 2022 年的 52.9 億美元達到近 126.3 億美元的市場規模，2023-2030 年研究期間的CAGR為 11.49%。

皮膚過敏治療是指旨在解決和控制皮膚上出現的過敏反應的治療和藥物。當皮膚遇到觸發免疫反應的物質時，就會發生皮膚過敏、過敏性皮膚炎或接觸性皮膚炎。常見的過敏原包括某些食物、植物、金屬、化妝品和藥物。

市場動態

由於環境因素和生活方式的改變，皮膚過敏盛行率激增，刺激了對有效治療解決方案的需求。醫學研究和技術的進步做出了重大貢獻，導致了創新療法的發展並擴大了可用選擇的範圍。全球對醫療保健和健康的重視進一步推動了市場的成長，人們對皮膚健康的認知不斷增強，並且願意投資有效的治療方法。全球過敏性疾病和皮膚病的發生率不斷增加，可能與環境因素和過敏原暴露有關，凸顯了對專門且有效的皮膚過敏療法的需求。預計這一趨勢將推動正在進行的研究和開發活動，從而推出新的和改進的治療方法。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球皮膚過敏治療市場的各個細分市場進行了包容性評估。皮膚過敏治療行業的成長和趨勢為這項研究提供了整體方法。

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲皮膚過敏治療市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。皮膚過敏治療市場的主要參與者包括Stallergenes Greer、Thermo Fisher Scientific、Siemens Healthcare、Omega Diagnostics、JDP Therapeutics Inc.、Hycor Biomedical、HOB Biotech Group、Genentech Inc.、Hitachi Chemical Diagnostics、Danaher Corporation、BioMernosieux、Lincoln Dinostics 。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：皮膚過敏治療公司的競爭格局

皮膚過敏治療市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

公司股份分析
市場集中度
Stallergenes Greer

公司簡介
公司收入
產品
最近的發展

Thermo Fisher Scientific

公司簡介
公司收入
產品
最近的發展

Siemens Healthcare

公司簡介
公司收入
產品
最近的發展

Omega Diagnostics

公司簡介
公司收入
產品
最近的發展

JDP Therapeutics Inc.

公司簡介
公司收入
產品
最近的發展

Hycor Biomedical

公司簡介
公司收入
產品
最近的發展

HOB Biotech Group

公司簡介
公司收入
產品
最近的發展

Genentech Inc.

公司簡介
公司收入
產品
最近的發展

Hitachi Chemical Diagnostics

公司簡介
公司收入
產品
最近的發展

Danaher Corporation

公司簡介
公司收入
產品
最近的發展

BioMerieux

公司簡介
公司收入
產品
最近的發展

Lincoln Diagnostics

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR112113246

The global demand for Skin Allergy Therapeutics Market is presumed to reach the market size of nearly USD 12.63 BN by 2030 from USD 5.29 BN in 2022 with a CAGR of 11.49% under the study period 2023 - 2030.

Skin allergy therapeutics refers to treatments and medications designed to address and manage allergic reactions that manifest on the skin. Skin allergies, allergic dermatitis, or contact dermatitis occur when the skin encounters substances that trigger an immune response. Common allergens include certain foods, plants, metals, cosmetics, and medications.

MARKET DYNAMICS

A surge in the prevalence of skin allergies, attributed to environmental factors and changing lifestyles, fuels the demand for effective therapeutic solutions. Advances in medical research and technology contribute significantly, leading to the development of innovative treatments and expanding the range of available options. The global emphasis on healthcare and wellness further propels market growth, with a growing awareness of skin health and a willingness to invest in effective therapeutics. The increasing incidence of allergic conditions and skin disorders globally, potentially linked to environmental factors and allergen exposure, underscores the need for specialized and efficient skin allergy therapeutics. This trend is expected to drive ongoing research and development activities, resulting in the introduction of new and improved treatments.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of skin allergy therapeutics. The growth and trends of skin allergy therapeutics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the skin allergy therapeutics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Indications

Urticarial
Anaphylaxis
Conjunctivitis
Drug Allergy
Allergic Asthma
Allergy Rhinitis
Others.

By Type

Patch
Intradermal
Prick
Others

By End-User

Hospitals & Clinics
Diagnostic Centers
Others.

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Skin Allergy Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Skin Allergy Therapeutics market include Stallergenes Greer, Thermo Fisher Scientific, Siemens Healthcare, Omega Diagnostics, JDP Therapeutics Inc., Hycor Biomedical, HOB Biotech Group, Genentech Inc., Hitachi Chemical Diagnostics, Danaher Corporation, BioMerieux, Lincoln Diagnostics. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . SKIN ALLERGY THERAPEUTICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Indications
- 3.7.2 Market Attractiveness Analysis By Type
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL SKIN ALLERGY THERAPEUTICS MARKET ANALYSIS BY INDICATIONS

5.1 Overview by Indications
5.2 Historical and Forecast Data
5.3 Analysis by Indications
5.4 Urticarial Historic and Forecast Sales by Regions
5.5 Anaphylaxis Historic and Forecast Sales by Regions
5.6 Conjunctivitis Historic and Forecast Sales by Regions
5.7 Drug Allergy Historic and Forecast Sales by Regions
5.8 Allergic Asthma Historic and Forecast Sales by Regions
5.9 Allergy Rhinitis Historic and Forecast Sales by Regions
5.10. Others Historic and Forecast Sales by Regions

6 . GLOBAL SKIN ALLERGY THERAPEUTICS MARKET ANALYSIS BY TYPE

6.1 Overview by Type
6.2 Historical and Forecast Data
6.3 Analysis by Type
6.4 Patch Historic and Forecast Sales by Regions
6.5 Intradermal Historic and Forecast Sales by Regions
6.6 Prick Historic and Forecast Sales by Regions
6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL SKIN ALLERGY THERAPEUTICS MARKET ANALYSIS BY END-USER

7.1 Overview by End-user
7.2 Historical and Forecast Data
7.3 Analysis by End-user
7.4 Hospitals & Clinics Historic and Forecast Sales by Regions
7.5 Diagnostic Centers Historic and Forecast Sales by Regions
7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL SKIN ALLERGY THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE SKIN ALLERGY THERAPEUTICS COMPANIES

9.1. Skin Allergy Therapeutics Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF SKIN ALLERGY THERAPEUTICS INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Stallergenes Greer
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Thermo Fisher Scientific
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Siemens Healthcare
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Omega Diagnostics
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. JDP Therapeutics Inc.
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Hycor Biomedical
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. HOB Biotech Group
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Genentech Inc.
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Hitachi Chemical Diagnostics
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. Danaher Corporation
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments
10.13. BioMerieux
- 10.13.1. Company Overview
- 10.13.2. Company Revenue
- 10.13.3. Products
- 10.13.4. Recent Developments
10.14. Lincoln Diagnostics
- 10.14.1. Company Overview
- 10.14.2. Company Revenue
- 10.14.3. Products
- 10.14.4. Recent Developments